CTOs on the Move

Medivance

www.medivance.com

 
Medivance is a Louisville, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.medivance.com
  • 500 S Arthur Ave Ste 100
    Louisville, CO USA 80027
  • Phone: 303.926.1917

Executives

Name Title Contact Details

Similar Companies

InteliFUSE

InteliFUSE is a New Orleans, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AIC-Isreal

AIC-Isreal is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LuxCath

LuxCath is the leader in using fluorescence and optics to directly view lesions during cardiac ablation procedures. The company`s breakthrough technology offers the potential for dramatic evolution in the way ablation procedures are performed by assessing tissue contact and enabling direct lesion progression monitoring. LuxCath`s patented solution aims to ensure the quality of catheter lesions at the moment they are made. LuxCath enables constant optical tissue contact assessment and provides valuable lesion formation and progression information during each ablation.

BioSig

BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.

Twine Health

Twine Health is new kind of healthcare technology company that takes a person-centric approach to collaborative care. Most patient-centric paradigms are infected by the age-old assumption that patients are their conditions, and carry the hubris that patients can be "fixed" by throwing resources at them. To us, patients are people, not numbers. We strive to give them tools to easily understand and manage their unique health situation, and enhance relationships with their care teams.